600252.SS · 中恒集团
China A-shares · RS rating 90 · As of 2026-10-14
| Price | 2.48 CNY |
|---|---|
| 1-day change | +10.2% |
| RS rating (overall / 1M / 3M / 12M) | 90 / 94 / 94 / 56 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 34 / 40 / 27 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +4.2% |
| Distance from 52-week high | +17.6% |
| Market cap (USD) | $1.0B |